Ion Channel Modulators
- VX661 [orb181347]
[1152311-62-0]
520.5
C26H27F3N2O6
C(C1=CC=C2OC(F)(F)OC2=C1)(C(NC1C(F)=CC2=C(C=1)C=C(C(C)(C)CO)N2C[C@H](O)CO)=O)1CC1
1000 mg, 100 mg, 250 mg - Sodium-Channel-inhibitor-1 [orb181326]
[1198117-23-5]
473.42
C24H19F4N3O3
O=C(C1N(CCC2=NC=CC=C2)C(C3=C1C(F)=CC=C3)=O)NCC4=CC=C(OC(F)(F)F)C=C4
1000 mg, 100 mg, 250 mg - PPQ-102 [orb181305]
[931706-15-9]
438.48
C26H22N4O3
C12N3C(C4=CC=CC=C4)=C4C(=O)N(C)C(=O)N(C)C4=C3C(C3=CC=C(C)O3)NC=1C=CC=C2
1000 mg, 100 mg, 250 mg - Mibefradil-dihydrochloride [orb181288]
[116666-63-8]
568.55
C29H40Cl2FN3O3
O=C(O[C@@]1(CCN(CCCC2=NC3=CC=CC=C3N2)C)[C@@H](C(C)C)C4=C(C=C(F)C=C4)CC1)COC.[H]Cl.[H]Cl
1000 mg, 100 mg, 250 mg - KU14R [orb181273]
[189224-48-4]
214.26
C13H14N2O
CCC1(C2=NC=CN2)OC3=CC=CC=C3C1
1000 mg, 100 mg, 250 mg - TAK-438 [orb181155]
[1260141-27-2]
461.46
C17H16FN3O2S.C4H4O4
N(S(C1=CC=CN=C1)(=O)=O)1C(C2=CC=CC=C2F)=CC(CNC)=C1.C(O)(=O)/C=C/C(O)=O
1000 mg, 100 mg, 250 mg - Ralfinamide [orb181142]
[202825-45-4]
398.45
C17H19FN2O2.CH3SO3H
OS(=O)(C)=O.FC1=CC=CC=C1COC2=CC=C(CN[C@@H](C)C(N)=O)C=C2
1000 mg, 100 mg, 250 mg - Rufinamide [orb181120]
[106308-44-5]
238.1935
C10H8F2N4O
NC(=O)C1=CN(N=N1)CC2=C(F)C=CC=C2F
1000 mg, 100 mg, 250 mg - ICILIN [orb181068]
[36945-98-9]
311.3
C16H13N3O4
C(=O)1N(C2=CC=CC=C2O)CC=C(C2=CC=CC([N+]([O-])=O)=C2)N1
1000 mg, 100 mg, 250 mg - IOWH-032 [orb181036]
[1191252-49-9]
545.18
C22H15Br2N3O4
BrC1=C(O)C(Br)=CC(C2=NOC(C(NCC3=CC=C(OC4=CC=CC=C4)C=C3)=O)=N2)=C1
1000 mg, 100 mg, 250 mg
